{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:19:06Z","timestamp":1783912746317,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s11064-021-03333-x","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T12:03:12Z","timestamp":1619438592000},"page":"1859-1868","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["MicroRNA-93 Blocks Signal Transducers and Activator of Transcription 3 to Reduce Neuronal Damage in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"46","author":[{"given":"Xiufeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"issue":"5","key":"3333_CR1","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM et al (2017) Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 32(5):739\u2013749","journal-title":"Mov Disord"},{"issue":"2","key":"3333_CR2","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/jcm9020504","volume":"9","author":"A Picca","year":"2020","unstructured":"Picca A et al (2020) Mitochondrial signatures in circulating extracellular vesicles of older adults with Parkinson\u2019s disease: results from the EXosomes in PArkiNson\u2019s Disease (EXPAND) study. J Clin Med 9(2):504","journal-title":"J Clin Med"},{"issue":"6357","key":"3333_CR3","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla LF et al (2017) Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science 357(6357):1255\u20131261","journal-title":"Science"},{"issue":"6","key":"3333_CR4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mcp.2016.11.001","volume":"30","author":"CM Lill","year":"2016","unstructured":"Lill CM (2016) Genetics of Parkinson\u2019s disease. Mol Cell Probes 30(6):386\u2013396","journal-title":"Mol Cell Probes"},{"key":"3333_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fnagi.2016.00036","volume":"8","author":"AG Hoss","year":"2016","unstructured":"Hoss AG et al (2016) microRNA profiles in Parkinson\u2019s disease prefrontal cortex. Front Aging Neurosci 8:36","journal-title":"Front Aging Neurosci"},{"key":"3333_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neulet.2017.02.045","volume":"644","author":"X-Y Cao","year":"2017","unstructured":"Cao X-Y et al (2017) MicroRNA biomarkers of Parkinson\u2019s disease in serum exosome-like microvesicles. Neurosci Lett 644:94\u201399","journal-title":"Neurosci Lett"},{"key":"3333_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.parkreldis.2015.11.014","volume":"22","author":"H Ding","year":"2016","unstructured":"Ding H et al (2016) Identification of a panel of five serum miRNAs as a biomarker for Parkinson\u2019s disease. Parkinsonism Relat Disord 22:68\u201373","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"3333_CR8","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","volume":"36","author":"AD Thome","year":"2016","unstructured":"Thome AD et al (2016) microRNA-155 regulates alpha-synuclein-induced inflammatory responses in models of Parkinson disease. J Neurosci 36(8):2383\u20132390","journal-title":"J Neurosci"},{"issue":"12","key":"3333_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/cells7120245","volume":"7","author":"Y Taguchi","year":"2018","unstructured":"Taguchi Y, Wang H (2018) Exploring MicroRNA biomarkers for Parkinson\u2019s disease from mRNA expression profiles. Cells 7(12):245","journal-title":"Cells"},{"issue":"2","key":"3333_CR10","first-page":"993","volume":"8","author":"S Li","year":"2016","unstructured":"Li S et al (2016) MicroRNA-7 inhibits neuronal apoptosis in a cellular Parkinson\u2019s disease model by targeting Bax and Sirt2. Am J Transl Res 8(2):993","journal-title":"Am J Transl Res"},{"issue":"7","key":"3333_CR11","doi-asserted-by":"publisher","first-page":"8648","DOI":"10.1096\/fj.201900363R","volume":"33","author":"L Yao","year":"2019","unstructured":"Yao L et al (2019) MicroRNA-124 regulates the expression of p62\/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson\u2019s disease. FASEB J 33(7):8648\u20138665","journal-title":"FASEB J"},{"issue":"7","key":"3333_CR12","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/onc.2010.465","volume":"30","author":"L Fang","year":"2011","unstructured":"Fang L et al (2011) MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-\u03b28. Oncogene 30(7):806","journal-title":"Oncogene"},{"issue":"1","key":"3333_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/jnc.13534","volume":"137","author":"T Yang","year":"2016","unstructured":"Yang T et al (2016) Elevated serum miR-93, miR-191, and miR-499 are noninvasive biomarkers for the presence and progression of traumatic brain injury. J Neurochem 137(1):122\u2013129","journal-title":"J Neurochem"},{"key":"3333_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.neulet.2018.08.025","volume":"685","author":"D-J Choi","year":"2018","unstructured":"Choi D-J, Kwon J-K, Joe E-H (2018) A Parkinson\u2019s disease gene, DJ-1, regulates astrogliosis through STAT3. Neurosci Lett 685:144\u2013149","journal-title":"Neurosci Lett"},{"issue":"4","key":"3333_CR15","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.bbrc.2019.08.140","volume":"519","author":"J Zhang","year":"2019","unstructured":"Zhang J et al (2019) miR-let-7a suppresses \u03b1-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson\u2019s disease. Biochem Biophys Res Commun 519(4):740\u2013746","journal-title":"Biochem Biophys Res Commun"},{"issue":"75","key":"3333_CR16","doi-asserted-by":"publisher","first-page":"71328","DOI":"10.1039\/C6RA11759G","volume":"6","author":"B Wang","year":"2016","unstructured":"Wang B et al (2016) Neuroprotective effects of nitidine in Parkinson\u2019s disease models through inhibiting microglia activation: role of the Jak2\u2013Stat3 pathway. RSC Adv 6(75):71328\u201371337","journal-title":"RSC Adv"},{"key":"3333_CR17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fncel.2018.00529","volume":"12","author":"A Yan","year":"2019","unstructured":"Yan A et al (2019) Idebenone alleviates neuroinflammation and modulates microglial polarization in LPS-stimulated BV2 cells and MPTP-induced Parkinson\u2019s disease mice. Front Cell Neurosci 12:529","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"3333_CR18","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/nm0996-1017","volume":"2","author":"P Hantraye","year":"1996","unstructured":"Hantraye P et al (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP\u2013induced Parkinsonism in baboons. Nat Med 2(9):1017\u20131021","journal-title":"Nat Med"},{"issue":"3","key":"3333_CR19","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.celrep.2017.12.066","volume":"22","author":"BA Friedman","year":"2018","unstructured":"Friedman BA et al (2018) Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of Alzheimer\u2019s disease not evident in mouse models. Cell Rep 22(3):832\u2013847","journal-title":"Cell Rep"},{"issue":"1","key":"3333_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.nbd.2010.09.005","volume":"41","author":"M Burguillos","year":"2011","unstructured":"Burguillos M et al (2011) Apoptosis-inducing factor mediates dopaminergic cell death in response to LPS-induced inflammatory stimulus: evidence in Parkinson\u2019s disease patients. Neurobiol Dis 41(1):177\u2013188","journal-title":"Neurobiol Dis"},{"issue":"5","key":"3333_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1472-8206.2008.00616.x","volume":"22","author":"G Dutta","year":"2008","unstructured":"Dutta G, Zhang P, Liu B (2008) The lipopolysaccharide Parkinson\u2019s disease animal model: mechanistic studies and drug discovery. Fundam Clin Pharmacol 22(5):453\u2013464","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"3333_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/glia.20225","volume":"52","author":"L Qin","year":"2005","unstructured":"Qin L et al (2005) Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation. Glia 52(1):78\u201384","journal-title":"Glia"},{"issue":"1","key":"3333_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","volume":"11","author":"Y Zhou","year":"2016","unstructured":"Zhou Y et al (2016) MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Mol Neurodegener 11(1):28","journal-title":"Mol Neurodegener"},{"issue":"1","key":"3333_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12974-018-1053-4","volume":"15","author":"L Yao","year":"2018","unstructured":"Yao L et al (2018) MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson\u2019s disease. J Neuroinflammation 15(1):13","journal-title":"J Neuroinflammation"},{"key":"3333_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.intimp.2017.01.027","volume":"46","author":"X-T Yan","year":"2017","unstructured":"Yan X-T et al (2017) MicroRNA-93 alleviates neuropathic pain through targeting signal transducer and activator of transcription 3. Int Immunopharmacol 46:156\u2013162","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"3333_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ydbio.2008.11.016","volume":"326","author":"KM Foshay","year":"2009","unstructured":"Foshay KM, Gallicano GI (2009) miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation. Dev Biol 326(2):431\u2013443","journal-title":"Dev Biol"},{"issue":"16","key":"3333_CR27","first-page":"5295","volume":"22","author":"L Xiong","year":"2018","unstructured":"Xiong L, Yu K, Zhen S (2018) MiR-93 blocks STAT3 to alleviate hepatic injury after ischemia\u2013reperfusion. Eur Rev Med Pharmacol Sci 22(16):5295\u20135304","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"11","key":"3333_CR28","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9(11):798\u2013809","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3333_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccr.2009.01.009","volume":"15","author":"J Bromberg","year":"2009","unstructured":"Bromberg J, Wang TC (2009) Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 15(2):79\u201380","journal-title":"Cancer Cell"},{"key":"3333_CR30","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/327089","author":"M Liu","year":"2011","unstructured":"Liu M, Bing G (2011) Lipopolysaccharide animal models for Parkinson\u2019s disease. Parkinson\u2019s Dis. https:\/\/doi.org\/10.4061\/2011\/327089","journal-title":"Parkinson\u2019s Dis"},{"key":"3333_CR31","first-page":"600","volume":"60","author":"L Forno","year":"1993","unstructured":"Forno L et al (1993) Similarities and differences between MPTP-induced parkinsonsim and Parkinson\u2019s disease. Neuropathologic considerations. Adv Neurol 60:600\u2013608","journal-title":"Adv Neurol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03333-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-021-03333-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03333-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T09:37:56Z","timestamp":1623145076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-021-03333-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["3333"],"URL":"https:\/\/doi.org\/10.1007\/s11064-021-03333-x","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,26]]},"assertion":[{"value":"11 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical clearance was obtained through the Ethics Review Committee, Faculty of Medicine, Union Hospital and the informed consent was obtained from all participants. Data collected from participants were kept confidential and were accessible only to the researchers.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}